Community Healthcare Trust (CHCT) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
10 Sep, 2026Executive summary
Portfolio consists of 197 properties across 36 states, totaling $1.25B in gross real estate investments and 4.5M sq. ft., diversified by asset type, operator, and geography.
Net income for Q2 2026 was $2.4 million, reversing a net loss in Q2 2025, driven by higher rental income and lower expenses.
Strategic plan focuses on dividend rightsizing, capital allocation for acquisitions, redevelopment, occupancy growth, and operating improvements.
Quarterly dividend reduced by 31% to $0.33 per share, lowering AFFO payout ratio to 60% and freeing $25–$30 million for growth initiatives over two years.
Expanded asset management, leasing, and construction teams to accelerate leasing and portfolio optimization.
Financial highlights
Q2 2026 revenue was $31.2M, up 7% year-over-year; AFFO per share increased 12% to $0.56; FFO per share was $0.48.
Net income per share was $0.06 for Q2 2026, compared to a loss of $0.50 per share in Q2 2025.
Annualized NOI stands at $101.4M; portfolio occupancy at 89.8%.
Debt/total capitalization at 43.9% as of Q2 2026; net debt to Adjusted EBITDAre annualized at 6.0x.
Dividend payout ratio targeted at 60%-65% of AFFO, with annual dividend review.
Outlook and guidance
Targeting improvement in leased occupancy from 89.8% to 92% by end of 2027, with over 100,000 sq. ft. of new leases signed year-to-date.
$99M acquisition pipeline under contract, with expected yields of 9-10% and ~2.5% escalators; closings anticipated through 2027.
Redevelopment projects expected to yield 9%-12% on cost, with $10M-$15M in projects ongoing annually.
$70M+ in marketed dispositions to fund new acquisitions, aiming for growth without new equity issuance.
Management expects to fund acquisitions and improvements through cash from operations, debt, equity issuances, or asset sales.
Latest events from Community Healthcare Trust
- Net income and AFFO rose, with $99 million in acquisitions pending and a $0.48 dividend declared.CHCT
Q1 2026 - Proxy covers director elections, pay alignment, auditor ratification, and ESG priorities.CHCT
Proxy Filing - Key votes include director elections, executive pay, and auditor ratification for 2026.CHCT
Proxy Filing - Q4 2025 saw 5.6% revenue growth, $14.4M net income, and a raised dividend.CHCT
Q4 2025 - Healthcare REIT launches $500M shelf, including $300M ATM equity, to fund growth and repay debt.CHCT
Registration Filing - Revenue up 3.1%, net income down 49.9%, $400M revolver expanded, and dividend growth continues.CHCT
Q3 2024 - Net loss from credit loss reserve overshadowed rental growth, but acquisitions and dividend increases continued.CHCT
Q2 2024 - Revenue rose to $30.1M, but net income and AFFO fell as costs increased and acquisitions continued.CHCT
Q1 2025 - AFFO and FFO per share declined year-over-year, but acquisitions and dividend growth continued.CHCT
Q4 2024